Biocure Technology Inc.
CUREX
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.20K | 3.90K | 12.50K | 19.80K | 21.20K |
| Total Receivables | 5.60K | 4.90K | 5.40K | -- | 3.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 44.90K | 8.90K | 17.90K | 19.80K | 24.70K |
|
|
|||||
| Total Current Assets | 44.90K | 8.90K | 17.90K | 19.80K | 24.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.49M | 1.38M | 1.38M | 1.47M | 1.46M |
|
|
|||||
| Total Accounts Payable | 392.10K | 394.60K | 417.70K | 291.90K | 288.20K |
| Total Accrued Expenses | 18.30K | 17.40K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 30.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 2.70K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 410.40K | 412.00K | 417.70K | 291.90K | 321.50K |
|
|
|||||
| Total Current Liabilities | 410.40K | 412.00K | 417.70K | 291.90K | 321.50K |
| Long-Term Debt | 39.50K | 36.00K | 34.50K | 35.20K | -- |
| Short-term Debt | -- | -- | -- | -- | 30.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 450.00K | 447.90K | 452.20K | 327.10K | 321.50K |
|
|
|||||
| Common Stock & APIC | 13.03M | 12.30M | 12.29M | 13.08M | 12.92M |
| Retained Earnings | -17.50M | -16.59M | -16.56M | -17.49M | -17.25M |
| Treasury Stock & Other | 5.50M | 5.22M | 5.21M | 5.55M | 5.48M |
| Total Common Equity | 1.04M | 928.40K | 931.80K | 1.15M | 1.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04M | 928.40K | 931.80K | 1.15M | 1.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04M | 928.40K | 931.80K | 1.15M | 1.14M |
|
|
|||||